ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative

Neurology

Volumn 48, Issue 1, 1997, Pages 139-147

  Blacker, D ^a   Haines, J L ^a   Rodes, L ^a   Terwedow, H ^a   Go, R C P ^b   Harrell, L E ^b   Perry, R T ^b   Bassett, S S ^c   Chase, G ^c   Meyers, D ^c   Albert, M S ^a   Tanzi, R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PEDIGREE; PRIORITY JOURNAL; RISK ASSESSMENT; SIBLING;

EID: 17744410836     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.1.139     Document Type: Article

References (45)

1. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation of the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
2. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a novel gene bearing missense mutations in early familial Alzheimer disease. Nature 1995;375:754-760.
3. Levy-Lehad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977.
4. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased freauency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;190:1977-1981.
5. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
6. Roses AD, Pericak-Vance M. Alzheimer's disease and other dementias. In: Emery EH, Rimoin DL, eds. Principles and practice of medical genetics. 3rd ed. Edinburgh: Churchill Livingston, 1995.
7. Locke, P, Conneally PM, Tanzi RE, et al. APOE and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases. Genet Epidemiol 1995;12:83-92.
8. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995;45:1323-1328.
9. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78.
10. Okuizumi K, Onodera O, Tanaka H, et al. ApoE-∈4 and early-onset Alzheimer's [letter]. Nat Genet 1994;7:10-11.
11. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923.
12. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein ∈4 allele frequency in the oldest old Alzheimer's disease patients and cognitively normal individuals. Neurology 1994;44:1513-1516.
13. Asada T, Kariya T, Yamagata Z, Kinoshita T, Asaka A. Apolipoprotein E allele in centenarians. Neurology 1996;46:1484.
14. Sobel E, Louhija J, Sulkava R, et al. Lack of association of apolipoprotein E allele ∈4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1996;46:903-907.
15. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-259.
16. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995;38:6-14.
17. Nalbantoglu J, Gilfix B, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994;36:889-895.
18. Seshadri S, Drachman D, Lippa C. Apolipoprotein E ∈4 allele and the lifetime risk of Alzheimer's disease: what physicians know, and what they should know. Arch Neurol 1995;52: 1074-1079.
19. Blacker D, Albert M, Bassett S, Go R, Harrell L, Folstein M. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. Arch Neurol 1994;51:1198-1204.
20. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group Under the Auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
21. Khachaturian Z. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1105.
22. Hixson J, Vernier D. Restriction isotyping of human polipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
23. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. JAMA 1994;272:1666-1671.
24. Menzel H-J, Kladetzky R-G, Assman G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983;3:310-315.
25. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
26. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754.
27. Meyers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E ∈4 association with dementia in a population-based study: the Framingham Study. Neurology 1996;46:673-677.
28. Davignon J, Bouthillier D, Nestruck AC, Sing CF. Apolipoprotein E polymorphism and atherosclerosis: insight from a study of octogenarians. Trans Am Clin Assoc 1988;99:100-110.
29. Schacter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32.
30. Schellenberg GD, Deeb SS, Boehnke ML, et al. Association of apolipoprotein CII allele with familial dementia of the Alzheimer's type. J Neurogenet 1987;4:97-108.
31. Weeks DE, Lange K. The affected-pedigree-member method of linkage analysis. Am J Hum Genet 1988;42:315-326.
32. S.A.G.E. Statistical Analysis for Genetic Epidemiology, Release 2.1, 1994. Computer program package available from the Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio.
33. Pocock S, Hughes M, Lee R. Statistical problems in the reporting of clinical trials. N Engl J Med 1987;317:426-432.
34. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer disease. Nat Genet 1994;7:180-184.
35. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993;39:2125-2129.
36. Kervinen K, Savolainen MJ, Salokannel J, et al. Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians. Atherosclerosis 1994;105:89-95.
37. Heston L, Mastri A. Age at onset of Pick's and Alzheimer's dementia: implications for diagnosis and research. J Gerontol 1982;37:422-426.
38. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer's Disease. Statement on use of apolipoprotein E testing for Alzheimer's disease. JAMA 1995;274:1627-1629.
39. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease position statement. Lancet 1996;347:1091-1095.
40. Farrer LA, O'Sullivan D, Cupples LA, Growdon JH, Myers RH. Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann Neurol 1989;25:485-493.
41. Breitner JCS, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations. Neurology 1988;38: 207-212.
42. Farrer LA, Myers RH, Cupples LA, et al. Transmission and age-at-onset patterns in familial Alzheimer's disease: evidence for heterogeneity. Neurology 1990;38:395-403.
43. Lautenschlager NT, Cupples LA, Rao VS, et al. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old? Neurology 1996;46:641-650.
44. Roses AD, Devlin B, Conneally PM, et al. Measuring the genetic contribution of APOE in late-onset Alzheimer disease (AD) [abstract]. Am J Hum Genet 1995;57:A202.
45. Tanzi RE, Bush AI, Wasco W. Genetic studies of Alzheimer's disease: lessons learned and future imperatives. Neurobiol Aging 1994;15(suppl 2):S145-S148.